Literature DB >> 29308550

Mycophenolic acid induces differentiation of Toxoplasma gondii RH strain tachyzoites into bradyzoites and formation of cyst-like structure in vitro.

Kitzia N Castro-Elizalde1, Pedro Hernández-Contreras1, Carlos J Ramírez-Flores1, Sirenia González-Pozos2, Carmen T Gómez de León1, Mónica Mondragón-Castelán1, Ricardo Mondragón-Flores3.   

Abstract

The biochemical and structural changes that occur during the conversion of Toxoplasma gondii tachyzoites to bradyzoites and the formation of tissue cyst are not well understood. Maintaining cells infected with T. gondii type II and III strains under stress conditions induces the tachyzoite-bradyzoite in vitro differentiation, along with the formation of cyst-like structures. However, due to the long exposure to such conditions required to induce the differentiation, the severe damages in the host cell and the low encystation frequency, it has been difficult to dissect in more detail these processes. Here, we successfully induced the in vitro formation of Toxoplasma cysts-like structures from tachyzoites of the type I RH strain by treating with mycophenolic acid, an inhibitor of the inosine monophosphate dehydrogenase. Mycophenolic acid is a drug widely used for HXGPRT positive selection of Toxoplasma mutant strains along with xanthine incubation in the culture medium; under such conditions, formation of tissue cysts has not been reported. We show that the exposure of extracellular tachyzoites to mycophenolic acid in absence of xanthine, followed by host cell invasion, triggered their differentiation into cyst-like structures. The differential expression of CST1, BAG1, and SAG1 molecules, as well as the structural modifications of infected cells, was characterized during the formation of cyst-like structures in vitro. These findings will allow the characterization of signaling pathways involved in tachyzoite to bradyzoite conversion and formation of tissue cysts.

Entities:  

Keywords:  Apicomplexan; Differentiation; Inosine monophosphate dehydrogenase; Mycophenolic acid; Tissue cyst; Toxoplasma

Mesh:

Substances:

Year:  2018        PMID: 29308550     DOI: 10.1007/s00436-017-5738-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  42 in total

Review 1.  Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics.

Authors:  K H Downing
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

2.  Recent expansion of Toxoplasma through enhanced oral transmission.

Authors:  C Su; D Evans; R H Cole; J C Kissinger; J W Ajioka; L D Sibley
Journal:  Science       Date:  2003-01-17       Impact factor: 47.728

3.  Induction and regulation of conoid extrusion in Toxoplasma gondii.

Authors:  M González Del Carmen; M Mondragón; S González; R Mondragón
Journal:  Cell Microbiol       Date:  2009-02-27       Impact factor: 3.715

Review 4.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 5.  Innate immunity to Toxoplasma gondii infection.

Authors:  Felix Yarovinsky
Journal:  Nat Rev Immunol       Date:  2014-02       Impact factor: 53.106

6.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

7.  In vitro observation of the stage conversion of transgenic Toxoplasma gondii RH strain expressing dual fluorescent proteins.

Authors:  Qijun Song; Ximeng Sun; Yongsheng Ji; Xinlei Yan; Jun Zou; Shiyun Zhao; Xun Suo; Xingquan Zhu; Xianyong Liu
Journal:  Acta Parasitol       Date:  2016-09-01       Impact factor: 1.440

8.  Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.

Authors:  W Bohne; J Heesemann; U Gross
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  A new type of quinoxalinone derivatives affects viability, invasion, and intracellular growth of Toxoplasma gondii tachyzoites in vitro.

Authors:  Norma Rivera Fernández; Mónica Mondragón Castelán; Sirenia González Pozos; Carlos J Ramírez Flores; Ricardo Mondragón González; Carmen T Gómez de León; Kitzia N Castro Elizalde; Yovani Marrero Ponce; Vicente J Arán; Miriam A Martins Alho; Ricardo Mondragón Flores
Journal:  Parasitol Res       Date:  2016-02-18       Impact factor: 2.289

10.  Disruption of microtubules uncouples budding and nuclear division in Toxoplasma gondii.

Authors:  Naomi S Morrissette; L David Sibley
Journal:  J Cell Sci       Date:  2002-03-01       Impact factor: 5.285

View more
  3 in total

1.  The beta subunit of AMP-activated protein kinase is critical for cell cycle progression and parasite development in Toxoplasma gondii.

Authors:  Jichao Yang; Xuke Yang; Anqi Liu; Yaqiong Li; Zhipeng Niu; Congcong Lyu; Xiaohan Liang; Ningbo Xia; Jianmin Cui; Mingjun Li; Ping Wu; Chao Peng; Bang Shen
Journal:  Cell Mol Life Sci       Date:  2022-09-28       Impact factor: 9.207

2.  Anti-toxoplasma, antioxidant and cytotoxic activities of Pleopeltis crassinervata (Fée) T. Moore hexane fraction.

Authors:  Jhony Anacleto-Santos; Perla López-Camacho; Ricardo Mondragón-Flores; Elisa Vega-Ávila; Gustavo Basurto Islas; Mónica Mondragón-Castelán; Elba Carrasco-Ramírez; Norma Rivera-Fernández
Journal:  Saudi J Biol Sci       Date:  2019-12-31       Impact factor: 4.219

3.  Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii.

Authors:  Débora Chaves Cajazeiro; Paula Pereira Marques Toledo; Natália Ferreira de Sousa; Marcus Tullius Scotti; Juliana Quero Reimão
Journal:  Pharmaceutics       Date:  2022-08-05       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.